“Overcoming breast cancer drug resistance with mTOR inhibitors”. Could it be a myth or a real possibility in the short-term future? Nadia MargaritiStephen B. FoxDaniele Generali Review 14 October 2010 Pages: 599 - 606
Are we missing the mTOR target in breast cancer? Stephen R. D. Johnston Invited Commentary 16 October 2010 Pages: 607 - 611
Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today? Bernd GerberKristin HeintzeToralf Reimer Review 27 April 2011 Pages: 613 - 624
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials Wen-Bin ZhouQiang DingShui Wang Review 07 May 2011 Pages: 625 - 631
Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients Yasuto NaoiKazuki KishiShinzaburo Noguchi Preclinical study 29 August 2010 Pages: 633 - 641
Time to move forward from “first-generation” prognostic gene signatures in early breast cancer Christine DesmedtStefan MichielsChristos Sotiriou Invited Commentary 16 October 2010 Pages: 643 - 645
Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer Cha Kyong YomDong-Young NohHee Sung Kim Preclinical study 03 September 2010 Pages: 647 - 655
The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system Eliza WiercinskaHildegonda P. H. NaberPeter ten Dijke Preclinical study 05 September 2010 Pages: 657 - 666
The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor Yuxin LiQiang ShenPowel H. Brown Preclinical study 07 September 2010 Pages: 667 - 677
Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer J. Sven D. MieogMerlijn HuttemanAlexander L. Vahrmeijer Preclinical study 07 September 2010 Pages: 679 - 689
Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo J. E. BluffM. AmarzguiouiC. A. Staton Preclinical study 10 September 2010 Pages: 691 - 701
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome Michael J. CampbellNathan Y. TonlaarLaura J. Esserman Preclinical study 15 September 2010 Pages: 703 - 711
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer Gizeh Pérez-TenorioElin KarlssonOlle Stål Preclinical study 16 October 2010 Pages: 713 - 723
The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study E. J. MacaskillJ. M. S. BartlettJ. M. Dixon Clinical trial 13 October 2010 Pages: 725 - 734
Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery Naruto TairaKojiro ShimozumaNoriyuki Katsumata Clinical Trial 17 June 2011 Pages: 735 - 747
Occult breast carcinoma in breast reduction specimens in European women Amit GoyalSamuel G. CoulsonChristopher M. Caddy Clinical Trial 28 May 2011 Pages: 749 - 753
Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer Asgerdur SverrisdottirHemming JohanssonTommy Fornander Clinical trial 29 May 2011 Pages: 755 - 763
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients Seung Jin KimAkinori MasagoShinzaburo Noguchi Clinical trial 01 June 2011 Pages: 765 - 773
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study Keisei AnanShoshu MitsuyamaTadashi Ikeda Clinical trial 03 June 2011 Pages: 775 - 781
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial Sirwan HadadTakayuki IwamotoAlastair M. Thompson Clinical trial 08 June 2011 Pages: 783 - 794
Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry Corina J. G. van den HurkRenate EckelJutta Engel Epidemiology 11 February 2011 Pages: 795 - 805
Trends in improving survival in breast cancer: two steps forward but one step back? Stephen Chia Invited Commentary 12 April 2011 Pages: 807 - 809
Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis Wei ZhengXiu-Feng CongHua-Wei Zou Epidemiology 12 February 2011 Pages: 811 - 815
Alcohol consumption and breast cancer risk in Japanese women: The Miyagi Cohort Study Masaaki KawaiYuko MinamiNoriaki Ohuchi Epidemiology 12 February 2011 Pages: 817 - 825
Improved web-based calculators for predicting breast carcinoma outcomes James S. MichaelsonL. Leon ChenJerry Younger Epidemiology 15 February 2011 Pages: 827 - 835
Urinary cadmium and mammographic density in premenopausal women Scott V. AdamsPolly A. NewcombJohanna W. Lampe Epidemiology 15 February 2011 Pages: 837 - 844
Genomic rearrangements of the BRCA1 gene in Chilean breast cancer families: an MLPA analysis Alejandro SanchezPaola FaundezPilar Carvallo Epidemiology 15 February 2011 Pages: 845 - 853
Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population Hao ShenCheng LuHongbing Shen Epidemiology 18 February 2011 Pages: 855 - 861
Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer Katherine E. Reeder-HayesJohn BainbridgeWilliam R. Carpenter Epidemiology 22 February 2011 Pages: 863 - 871
A nationwide analysis of incidence and outcome of breast cancer in the country of Surinam, during 1994–2003 Rachel S. van LeeuwaardeMartinus A. VredeAnneke M. Westermann Epidemiology 22 February 2011 Pages: 873 - 881
Prediagnostic plasma enterolactone levels and mortality among women with breast cancer Anja OlsenJane ChristensenAnne Tjønneland Epidemiology 22 February 2011 Pages: 883 - 889
Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient M. Ángeles VillarongaIrene López-MateoBorja Belandia Brief Report 05 April 2011 Pages: 891 - 898
Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation J. E. PanoffJ. HurleyJ. L. Wright Brief Report 08 April 2011 Pages: 899 - 906
Low vitamin D status likely contributes to the link between periodontal disease and breast cancer William B. GrantBarbara J. Boucher Letter to the Editor 25 March 2011 Pages: 907 - 908
Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk Bo JinFusheng JiangZhishan Ding Letter to the Editor 26 March 2011 Pages: 909 - 912
The association between IGF1 CA repeat polymorphisms and breast cancer risk: appraisal of a recent meta-analysis Yan-Feng ZouFang WangXiao-Liang Feng Letter to the Editor 05 April 2011 Pages: 913 - 915
